Therefore, the aim of this study was the evaluation of the diagnostic performance of68Ga-PSMA-11 PET/CT for detection of primary prostate cancer in patients with increased PSA levels and comparison of the results to 18FEC PET/CT. This evidence concerns the gene FOLH1 and prostate carcinoma.